Compile Data Set for Download or QSAR
Report error Found 87 Enz. Inhib. hit(s) with Target = 'Serine/threonine-protein kinase mTOR [1360-2549]'
TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251623BDBM251623(US9453031, 46)
Affinity DataIC50: 38nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251621BDBM251621(US9453031, 44)
Affinity DataIC50: 44nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251635BDBM251635(US9453031, 72)
Affinity DataIC50: 45.3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251641BDBM251641(US9453031, 78)
Affinity DataIC50: 47nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251622BDBM251622(US9453031, 45)
Affinity DataIC50: 53nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251652BDBM251652(US9453031, 103)
Affinity DataIC50: 58nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251638BDBM251638(US9453031, 75)
Affinity DataIC50: 93nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251634BDBM251634(US9453031, 71)
Affinity DataIC50: 99.3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251647BDBM251647(US9453031, 93)
Affinity DataIC50: 117nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251578BDBM251578(US9453031, 1)
Affinity DataIC50: 146nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251630BDBM251630(US9453031, 67)
Affinity DataIC50: 151nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251637BDBM251637(US9453031, 74)
Affinity DataIC50: 152nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251582BDBM251582(US9453031, 5)
Affinity DataIC50: 194nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251656BDBM251656(US9453031, 109)
Affinity DataIC50: 224nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251633BDBM251633(US9453031, 70)
Affinity DataIC50: 226nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251650BDBM251650(US9453031, 101)
Affinity DataIC50: 227nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251624BDBM251624(US9453031, 61)
Affinity DataIC50: 228nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251658BDBM251658(US9453031, 112)
Affinity DataIC50: 235nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251626BDBM251626(US9453031, 63)
Affinity DataIC50: 252nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251581BDBM251581(US9453031, 4)
Affinity DataIC50: 274nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251615BDBM251615(US9453031, 38)
Affinity DataIC50: 275nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251617BDBM251617(US9453031, 40)
Affinity DataIC50: 279nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251632BDBM251632(US9453031, 69)
Affinity DataIC50: 336nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251618BDBM251618(US9453031, 41)
Affinity DataIC50: 381nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251619BDBM251619(US9453031, 42)
Affinity DataIC50: 412nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251606BDBM251606(US9453031, 29)
Affinity DataIC50: 435nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251643BDBM251643(US9453031, 80)
Affinity DataIC50: 501nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251627BDBM251627(US9453031, 64)
Affinity DataIC50: 505nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251604BDBM251604(US9453031, 27)
Affinity DataIC50: 550nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251583BDBM251583(US9453031, 6)
Affinity DataIC50: 558nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251655BDBM251655(US9453031, 108)
Affinity DataIC50: 579nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251602BDBM251602(US9453031, 25)
Affinity DataIC50: 582nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251608BDBM251608(US9453031, 31)
Affinity DataIC50: 586nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251585BDBM251585(US9453031, 8)
Affinity DataIC50: 588nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251588BDBM251588(US9453031, 11)
Affinity DataIC50: 604nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251605BDBM251605(US9453031, 28)
Affinity DataIC50: 785nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251611BDBM251611(US9453031, 34)
Affinity DataIC50: 808nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251592BDBM251592(US9453031, 15)
Affinity DataIC50: 851nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251593BDBM251593(US9453031, 16)
Affinity DataIC50: 852nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251629BDBM251629(US9453031, 66)
Affinity DataIC50: 854nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251628BDBM251628(US9453031, 65)
Affinity DataIC50: 921nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251616BDBM251616(US9453031, 39)
Affinity DataIC50: 1.24E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251646BDBM251646(US9453031, 92)
Affinity DataIC50: 1.24E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251644BDBM251644(US9453031, 82)
Affinity DataIC50: 1.59E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251584BDBM251584(US9453031, 7)
Affinity DataIC50: 1.62E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251601BDBM251601(US9453031, 24)
Affinity DataIC50: 1.67E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251596BDBM251596(US9453031, 19)
Affinity DataIC50: 1.76E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251597BDBM251597(US9453031, 20)
Affinity DataIC50: 1.82E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251651BDBM251651(US9453031, 102)
Affinity DataIC50: 1.82E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR [1360-2549](Human)
FundacióN Centro Nacional De Investigaciones OncolóGicas Carlos Iii

US Patent
LigandChemical structure of BindingDB Monomer ID 251580BDBM251580(US9453031, 3)
Affinity DataIC50: 1.86E+3nMpH: 7.5 T: 2°CAssay Description:The enzymatic mTOR activity was measured using a LanthaScreen kinase activity assay (Invitrogen). The enzyme was purchased from Invitrogen (PV4754), ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2017
Entry Details
US Patent

Displayed 1 to 50 (of 87 total ) | Next | Last >>
Jump to: